Africa CDC’s new Continental Immunisation Strategy 2026-2030 aims to revive vaccine coverage as outbreaks rise and funding tightens. According to immunisation experts who helped develop it, coverage is failing to keep pace with population growth. In 2025, about 7.1 million African children (15.6% of those under a year old) missed even a single routine dose. Immunisation Gains in Africa are…
Tag: Vaccine Manufacturing
-
Africa Vaccine Procurement Framework Promises Security
Africa CDC and Aspen Pharmacare say they are in advanced discussions about a long-term demand-and-supply alignment plan that could reshape how African countries buy vaccines made on the continent. As part of these talks, officials are considering the Africa Vaccine Procurement Framework to support the process. They announced the engagement on the sidelines of the Africa Forward Summit in Nairobi.…
-
Biovac Expansion Fundraising: $20M Secured from France
South African vaccine manufacturer Biovac has secured a further $20m (R327m) from two French development finance institutions. This brings its total fundraising to $128m (R2.4bn) and leaves the company within striking distance of its $180m (R2.95bn) target. Moreover, this new investment marks a significant milestone in the ongoing Biovac expansion fundraising effort. Agence Française de Développement and its private-sector arm,…
-
African Vaccine Manufacturing Expansion Set For Biovac Site
The South African vaccine producer Biovac has announced a major expansion of its Cape Town operations. This is a significant development in African vaccine manufacturing. This ambitious project receives significant backing from the European Investment Bank (EIB) Group and the International Finance Corporation (IFC). The new financing package will help Biovac develop end-to-end production capabilities. The primary focus will initially…
-
One Health Summit Signals Renewed French Support for SA
France has sent a clear diplomatic signal to South Africa through health diplomacy. President Emmanuel Macron invited a South African delegation to the recent One Health Summit in Lyon. The move follows uncertainty after reports that South Africa was disinvited from attending the G7 meeting scheduled for June in Évian-les-Bains, Haute-Savoie. South Africa’s Health Minister, Aaron Motsoaledi, attended alongside business…
-
Afrigen Business Rescue: Cape Town Biotech Firm Seeks Investors
The Cape Town-based biotechnology firm, Afrigen Biologics, has officially entered business rescue. This move follows the financial collapse of the Avacare group, which holds a 51% majority stake in the company. The Industrial Development Corporation (IDC) holds the remaining 49% share. Afrigen gained international acclaim in 2022. It successfully developed an mRNA COVID-19 vaccine using publicly available data from Moderna.…
-
Regulatory Delays Threaten Africa’s Pharmaceutical Ambition
Critical delays in aligning Africa’s pharmaceutical regulations with World Health Organisation (WHO) standards are jeopardising the continent’s R1.25-trillion ($70bn) goal. They aim to become a self-sufficient pharmaceuticals manufacturing hub, according to a top industry executive. Stavros Nicolaou, a senior executive at Aspen Pharmacare and chair of Pharmaceuticals Made in South Africa (Pharmisa), warned that this regulatory bottleneck is preventing African…
-
Local Medicine Manufacturing and National Health Security
In a strategic move to enhance local medicine manufacturing, Sahpra aims to fast-track the approval of locally made medicines. This is an effort to secure the national supply. Sahpra’s decision aims to address drug shortages and reduce reliance on imports. Furthermore, it aims to strengthen the nation’s pharmaceutical industry through initiatives in local medicine manufacturing. In a significant move to…
-
Biovac Secures Deal to Produce Pneumonia Vaccine
In a significant move for continental health security, Cape Town-based research group Biovac has announced a major technology transfer agreement with Indian pharmaceutical firm Biological E. The Biovac initiative will enable the company to produce and distribute a pneumococcal conjugate vaccine (PCV14) across Africa. This marks a vital step towards self-sufficiency in vaccine manufacturing. The partnership will accelerate the growth…